SVB Securities returns to Leerink Partners name following $100M buyout

A deal between SVB Financial Group and two biotech investing giants to sell its investment banking division, SVB Securities, has been approved, the company announced Thursday.
Click here to view original post

Advertisement — Advertise with Biotech Networks